Zevalin (Spectrum Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Zevalin drug offered from Spectrum Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Spectrum Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | ibritumomab tiuxetan |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2002-02-19 |
| END MARKETING DATE: | 0000-00-00 |
Zevalin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Zevalin from Spectrum Pharmaceuticals, Inc. |
| LABELER NAME: | Spectrum Pharmaceuticals, Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2002-02-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68152-103_281135c5-e842-4a8f-85d9-462c0ee8c51c |
| PRODUCT NDC: | 68152-103 |
| APPLICATION NUMBER: | BLA125019 |